Liping Luo

Also affiliated with Second People’s Hospital of Yibin, Northwest Normal University

Agricultural and Biological SciencesImmunology and MicrobiologyMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “CD6-targeted antibody-drug conjugate as a new therapeutic agent for T cell lymphoma”.

CD6-targeted antibody-drug conjugate as a new therapeutic agent for T cell lymphoma

Leukemia(2023)10.1038/s41375-023-01997-8

N/A

0DataRank · unranked

14 citations

Liping Luo, Lingjun Zhang, Joel Chen, Frank P. DiFilippo, Charlie Androjna +7 more

A CD6-targeted antibody-drug conjugate as a potential therapy for T cell–mediated disorders

JCI Insight(2023)10.1172/jci.insight.172914

N/A

0DataRank · unranked

14 citations

Liping Luo, Jin Chen, Rupesh Singh, William M. Baldwin, David A. Fox +5 more

A nanobody-based complement inhibitor targeting complement component 2 reduces hemolysis in a complement humanized mouse model of autoimmune hemolytic anemia

Clinical Immunology(2023)10.1016/j.clim.2023.109678

N/A

0DataRank · unranked

9 citations

Lingjun Zhang, Liping Luo, Maojing Yang, Yinghua Chen, Feng Lin +1 more